Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;20(Suppl 1):7–11. doi: 10.1002/clc.4960201304

History of echocardiographic contrast agents

Navin C Nanda 1,2
PMCID: PMC6655563  PMID: 9383596

Abstract

Since its experimental introduction over 30 years ago, the use of cardiac ultrasound has expanded expeditiously, particularly in the last decade. The inception of managed care has fueled this expansion because ultrasound technology has the potential to enhance cost‐effective diagnosis and medical care. Another important factor driving the growth of cardiac ultrasound has been the recent and rapid development of contrast echocardiography (CE). This diagnostic technique, involving the injection of a contrast agent to enhance ultrasound imaging, provides a safe, noninvasive means of directly assessing myocardial perfusion and a host of other aspects of cardiovascular health and integrity.

Keywords: history, contrast agents, perflenapent emulsion, EchoGen®, contrast echocardiography, Doppler, imaging

Full Text

The Full Text of this article is available as a PDF (1.8 MB).

References

  • 1. Gramiak R, Shah PM: Echocardiography of the aortic root. Invest Radio 1968; 3: 356–366 [DOI] [PubMed] [Google Scholar]
  • 2. Aronson S, Han LK: Stress echocardiography, contrast echocardiography and tissue characterization. Crit Care Clin 1996; 12: 429–450 [DOI] [PubMed] [Google Scholar]
  • 3. Gramiak R, Nanda NC: Contrast techniques in echocardiography In Echocardiography Congenital Heart Disease (Ed. Lundstrom NR.), p. 39–65. Biomedical Press, 1978. [Google Scholar]
  • 4. Gramiak R, Nanda NC: Structure identification in echocardiography In Cardiac Ultrasound (Eds. Gramiak R, Waag RC.), p. 29–46. St. Louis: The C.V. Mosby Co., 1975. [Google Scholar]
  • 5. Gramiak R, Nanda NC, Shah PM: Echocardiographic detection of the pulmonary valve. Radiology 1972; 102: 153–157 [DOI] [PubMed] [Google Scholar]
  • 6. Nanda NC: Contrast echocardiography In Progress in Cardiology (Eds. Goodwin JF, Yu PN.), p. 113–145. Philadelphia: Lea & Febiger, 1979. [Google Scholar]
  • 7. Nanda NC, Gramiak R, Manning JA: Echocardiography of the tricuspid valve in congenital left ventricular‐right atrial communication. Circulation 1975; 51: 269–272 [DOI] [PubMed] [Google Scholar]
  • 8. Nanda NC, Stewart S, Gramiak R, Manning JA: Echocardiographic evaluation of tricuspid valve incompetence by contrast injections. Clin Res 1976; 24: 233A [Google Scholar]
  • 9. Rothbard RL, Nanda NC: How to apply contrast echocardiographic techniques. J Cardiovasc Med 1983; 736–744
  • 10. Rothbard RL, Nanda NC: Contrast echocardiography. Seminars in Ultrasound 1981; 2: 167–172 [Google Scholar]
  • 11. Feigenbaum H: Echocardiography, 5th ed., p. 48 Philadelphia: Lea & Febiger, 1994. [Google Scholar]
  • 12. Shub C, Tajik AJ, Seward JB, Dines DE: Detecting intrapulmonary right‐to‐left shunt with contrast echocardiography. Mayo Clin Proc 1976; 51: 81–84 [PubMed] [Google Scholar]
  • 13. Correas J‐M, Quay SD: EchoGen® emulsion: A new ultrasound contrast agent based on phase shift colloids. Clin Radiol 1996; 51 (suppl 1): 11–14 [PubMed] [Google Scholar]
  • 14. Meltzer RS, Tickner EG, Popp RL: Why do the lungs clear ultrasonic contrast? Ultrasound Med Biol 1980; 6: 263–269 [DOI] [PubMed] [Google Scholar]
  • 15. Cosgrove D: Why do we need contrast agents for ultrasound? Clin Radiol 1996; 51 (suppl 1): I–4 [PubMed] [Google Scholar]
  • 16. Schürmann R, Schlief R: Saccharide‐based contrast agents: Characteristics and diagnostic potential. Radiol Med 1994; 87 (suppl 1): 15–23 [PubMed] [Google Scholar]
  • 17. Tokgözoglu SL, Caner B, Kabakçi G, Kes S: Measurement of right ventricular ejection fraction by contrast echocardiography. Int J Cardiol 1997; 59: 71–74 [DOI] [PubMed] [Google Scholar]
  • 18. Smith MD, Kwan OL, Reiser HJ, DeMaria AN: Superior intensity and reproducibility of SHU‐454, a new right heart contrast agent. J Am Coll Cardiol 1984; 3: 992–998 [DOI] [PubMed] [Google Scholar]
  • 19. Østensen J: AlbunexTM and beyond. Clin Radiol 1996; 51 (suppl 1): 8–10 [PubMed] [Google Scholar]
  • 20. Crouse LJ, Cheirif J, Hanley DE: Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: Results of the phase III Albunex® multicenter trial. J Am Coll Cardiol 1993; 22: 1494–1500 [DOI] [PubMed] [Google Scholar]
  • 21. Goens MB, Martin GR: Acoustic quantification: A new tool for diagnostic echocardiography. Curr Opin Cardiol 1996; 11: 52–60 [DOI] [PubMed] [Google Scholar]
  • 22. Quiñones MA, Cheirif J: New perspectives for perfusion imaging in echocardiography. Circulation 1991; 83 (suppl 3): 104–110 [PubMed] [Google Scholar]
  • 23. Villarraga HR, Foley DA, Mulvagh SL: Contrast echocardiography 1996: A review. Tex Heart Inst J 1996; 23: 90–97 [PMC free article] [PubMed] [Google Scholar]
  • 24. Melany ML, Grant EG: Clinical experience with sonographic contrast agents. Semin Ultrasound CT MR 1997; 18: 3–12 [DOI] [PubMed] [Google Scholar]
  • 25. Aggarwal KK, Gatewood RP, Nanda NC, Chopra KL: Improved transesophageal echocardiographic assessment of significant proximal narrowing of the left anterior descending and left circumflex coronary arteries using echo contrast enhancement. Am J Cardiol 1994; 73: 1131–1133 [DOI] [PubMed] [Google Scholar]
  • 26. Fan P, Czuwala PJ, Nanda NC, Rosenthal SM, Yoganathan A: Comparison of various agents in contrast enhancement of color Doppler flow images: An in vitro study. Ultrasound Med Biol 1993; 19: 45–57 [DOI] [PubMed] [Google Scholar]
  • 27. Garcia Del Rio C, Taylor GW, Nanda NC, Agrawal DI, Agrawal GG, Carvalho C, Espinal M, Becher H: Color Doppler visualization of intramyocardial coronary arteries using a new echo system: Effect of contrast enhancement and vasodilation. Echocardiography 1996; 13: 645–650 [DOI] [PubMed] [Google Scholar]
  • 28. Nanda NC: Advances in echo contrast enhancement In Advances in Echo‐Contrast (Ed. Nanda NC.). Dordrecht, Netherlands: Kluwer Academic Publishers, 1990. [Google Scholar]
  • 29. Schlief R, Staks T, Mahler M, Rufer M, Fritzsch T, Seifert W: Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent. Echocardiography 1990; 7: 61–64 [DOI] [PubMed] [Google Scholar]
  • 30. Ophir J, Parker KJ: Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989; 15: 319–333 [DOI] [PubMed] [Google Scholar]
  • 31. Mattrey RF, Scheible FW, Gosink BB, Leopold GR, Long DM, Higgins CB: Perfluoroctylbromide: A liver/spleen‐specific and tumor‐imaging ultrasound contrast material. Radiology 1982; 145: 759–762 [DOI] [PubMed] [Google Scholar]
  • 32. Fink IJ, Miller DL, Shawker TH, Girton M, Morrish K: Lipid emulsions as contrast agents for hepatic sonography: An experimental study in rabbits. Ultrason Imaging 1985; 7: 191–197 [DOI] [PubMed] [Google Scholar]
  • 33. Parker KJ, Tuthill TA, Lerner RM, Violante MR: A particulate contrast agent with potential for ultrasound imaging of liver. Ultrasound Med Biol 1987; 13: 555–566 [DOI] [PubMed] [Google Scholar]
  • 34. Quay S: USA; Patent numbers 5,409,688; 5.393.524: SONUS Pharmaceuticals, 1995.
  • 35. Skyba DM, Camarano G, Goodman NC, Price RJ, Skalak TC, Kaul S: Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS‐069, a second‐generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol 1996; 28: 1292–1300 [DOI] [PubMed] [Google Scholar]
  • 36. Chang PH, Shung KK, Levene HB: Quantitative measurements of second harmonic Doppler using ultrasound contrast agents. Ultrasound Med Biol 1996; 22: 1205–1214 [DOI] [PubMed] [Google Scholar]
  • 37. Schneider M, Arditi M, Barrau M‐B, Brochot J, Broillet A, Ventrone R, Yan F: BRI: A new ultrasonographic contrast agent based on sulfur hexafluoride‐filled microbubbles. Invest Radiol 1995; 30: 451–457 [DOI] [PubMed] [Google Scholar]
  • 38. Unger EC, Lund PJ, Shen D‐K: Nitrogen‐filled liposomes as a vascular US contrast agent: Preliminary evaluation. Radiology 1992; 185: 453–456 [DOI] [PubMed] [Google Scholar]
  • 39. Bauer A, Nahler M, Urbank A, Zomack M, Schlief R, Niendorf HP: Microvascular imaging—results from a Phase I study of the novel polymeric ultrasound contrast agent SHU 563A In Advances in Echo Imaging Using Contrast Enhancement, 2nd ed. (Eds. Nanda NC, Schlief R, Goldberg BB.), p. 685–690. Dordrecht/Boston/London: Kluwer Academic Publishers, 1997. [Google Scholar]
  • 40. Nanda NC, Raichlen JS: Contrast echocardiography today In Advances in Echo Imaging Using Contrast Enhancement. 2nd ed. (Eds. Nanda NC, Schlief R, Goldberg BB.), p. 209–216. Dordrecht/Boston/London: Kluwer Academic Publishers, 1997. [Google Scholar]
  • 41. Agrawal DI, Malhotra S, Nanda NC, Truffa CC, Agrawal G, Thakur AC, Jamil F, Taylor GW, Becher H: Harmonic power Doppler contrast echocardiography: Preliminary experiment results. Echocardiography November 1997. (in press [DOI] [PubMed]
  • 42. Agrawal G, Cape EG, Raichlen JS, Tirtaman C: Usefulness of combined color Doppler/contrast in providing complete delineation of left ventricular cavity. Am J Cardiol 1997; 80: 98–101 [PubMed] [Google Scholar]
  • 43. Tiemann K, Becher H, Bimmel D, Schlief FR, Nanda NC: Stimulated acoustic emission—non‐backscatter contrast effect of microbubbles seen with harmonic power Doppler imaging. Echocardiography 1997; 14: 65–69 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES